个人资料封面照片
您正在关注
关注用户错误。
该用户不允许他人关注他们。
您已经关注了这个用户。
您的会员计划仅允许0个关注。升级在此。
成功取消关注
取消关注用户错误
您已成功推荐
推荐用户错误。
出问题了,请刷新页面并重新尝试。
电子邮箱已成功验证。
用户头像
INDIA的国旗
new delhi, india
目前这里是11:43 上午
一月 18, 2014已加入
0 推荐

Nafees A.

@N9990655867

0.0 (0条评论)
0.0
0.0
0%
0%
INDIA的国旗
new delhi, india
不适用
工作已完成
不适用
在预算内
不适用
按时
不适用
重复雇用率

Formulation scientist

 An accomplished Pharmaceutical professional with expertise in all stages of drug lifecycle management and experience in strategy implementation and submission management, eager to contribute to the success of a progressive organization.  Adept at recognizing, analyzing and proven success in achieving company goals and objectives in all aspects of day-to-day regulatory affairs and quality assurance initiatives to several therapeutic areas.  Set goals, establish priorities, manage resources, and develop strategies to stay abreast of regulatory requirements including FDA, GCC, ICH guidelines and relevant government regulations (21 CFR, EU Directive). Perform extensive research and analysis to timely and effectively prepare regulatory submissions, with additional emphasis in delivering electronic submissions focused on implementing the eCTD.  Evaluate industry trends and use findings toward designing and executing strategies to boost company leveraging. Excel at interacting with broad populations, including C-level executives, vendors, clients, and contractors.  Prepare, review and approve submission documents for CTD/ eCTD compliance.  Prepare final electronic PDF navigational competencies to all documents by applying blue-text, bookmarks, and hypertext linking to better accommodate Regulatory/FDA reviewers at time of submission.  Manage the quality control of all blue-texted, bookmarked, and hyperlinked documents prepared for electronic submissions.  Worked closely and directly with Medical writers, Regulatory submissions, Biostatisticians, Data Management and internal and external clients.

联系Nafees A.询问您的工作详情

登录并通过聊天讨论所有细节。

评论

变更已保存
这里没有评论!

经验

Research associate

Evalueserve
2月 2014 - 现在
 Analyzing and extracting relevant information from supplier’s documents such as certificate of analysis, Material Safety datasheet etc.  Maintaining extracted information in a structured manner in client’s database.  Client communication/interaction.  Communication with various suppliers/ manufacturers to get information on raw material  Creating implementation and product support agreements.  Create a check list for all documents available and maintaining list, documents and records.  Acquire and maintain current knowledge of applicable regulatory requirements and scientific/technical issues in the region and discipline areas relevant to assigned projects.  Identify/confirm CAS number of chemicals.  Compositional analysis of formulations/ Chemicals to identify key constituents, impurities and additives  Literature survey.

教育

M Pharm (Pharmaceutics)

Jamia Hamdard, India 2010 - 2012
(2 年)

资质

GPAT

AICTE
2010
 Qualified Graduate Pharmacy Aptitude Test (GPAT 2010) with 96.70 Percentile.

出版物

Optimization of Gel Based System of Lercanidipine by Statistical Design for transdermal delivery: Histopathological Examination and Rheological Characterization

Journal of Biopharmaceutics Sciences
Objective of study: Our goal was to develop a transdermal gel formulation of lercanidipine by applying statistical approach for enhanced permeation and suitable application over skin. Methods: A 3-factors, 3-level Box-Behnken design were used to optimize the formulation. Ex vivo skin permeation studies were carried out to evaluate the responses such as flux, cumulative amount release in 24 hour and lag time using Franz-type diffusion cell. Confocal laser scanning microscopy (CLSM) of treated rat skin were

Solid Lipid Nanoparticle for the Oral Delivery of Decitabine: Formulation optimization, Characterization, Stability study and Ex-vivo Gut permeation study

. Science of Advanced Materials
The aim of current study was to develop solid lipid nanoparticles (SLNs) as novel lipid nanocarriers for oral delivery of Decitabine (DCB) using the cold homogenization technique. Box-Behnken design (33) with 17 experimental runs was used to achieve optimal formulations. The optimized batch was characterized by combining particle size distribution analysis, Z-potential, TEM, EE, DL, and DLS measurements, with rheological in-vitro drug release, accelerated stability, and ex-vivo gut permeation studies. The o

Stability indicating RP-HPLC method for the estimation of Decitabine in bulk drug and lipid based

International Journal of Pharma Sciences and Research
Purpose: The aim of our present work was to develop and validate a reverse phase high-performance liquid chromatography (RP-HPLC) method for the determination of Decitabine (DCB). The developed method was further applied to observe the degradation of DCB under various stress conditions. Methods: Chromatographic separation was achieved on C18, 250 × 4.6 mm, particle size 5 μm, Agilent column, using ammonium acetate (0.01M) as mobile phase with flow rate of 1mL/min and injection volume was 20 μL. Quantifi

Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies

Nanotechnology
The purpose of this study was to develop lipid drug conjugate (LDC) nanoparticles of decitabine (DCB) using stearic acid as a lipid to increase the permeability of the drug along with its protection from chemical degradation. The LDC was prepared by salt formation of DCB with stearic acid and followed by cold homogenization technique to produce the LDC nanoparticles. The role of key independent variables influencing on dependent variables were determined by using a Box–Behnken design. The optimized bat

Lipid baesd nanocarrier system for the potential oral delivery of decitabine:Formulation design, Characterization, ex vivo, and in vivo assessment.

International journal of pharmaceutics
The aim of this study was to design and fabricate nanostructured lipid carrier (NLC) for the potential oral delivery of decitabine (DCB). NLC was prepared by cold homogenization technique and optimized by the Box-Behnken experimental design. It was further characterized by particle size, zeta potential, transmission electron microscopy (TEM), atomic force microscopy (AFM), differential scanning calorimetry (DSC), X-ray diffraction (XRD), in vitro release study, and stability study. Moreover, ex vivo and in

Anal fissure nanocarrier of lercanidipine for enhanced transdermal delivery: Formulation optimization, ex vivo, and in vivo assessment

Expert opinion on drug delivery
Objective: Pathogenesis of anal fissure (AF) is associated with raised resting anal pressures (RAP) involving contraction of smooth muscle. Therefore, the drug delivery strategy should be customized to reduce this raised RAP. In this investigation, in order to achieve this task, a transdermal nanoemulsion (NE) gel of lercanidipine (LER) was developed and optimized to evaluate its permeation ability and in vivo performance. Further, the same formulation was explored for droplet size analysis, zeta pote

联系Nafees A.询问您的工作详情

登录并通过聊天讨论所有细节。

认证

优选威客
身份已验证
支付已验证
电话已验证
邮箱已验证
Facebook已关联
之前的用户 下一个用户
邀请已发送成功!
谢谢!我们已通过电子邮件向您发送了索取免费积分的链接。
发送电子邮件时出现问题。请再试一次。
已注册用户 发布工作总数
Freelancer ® is a registered Trademark of Freelancer Technology Pty Limited (ACN 142 189 759)
Copyright © 2024 Freelancer Technology Pty Limited (ACN 142 189 759)
加载预览
授予地理位置权限。
您的登录会话已过期而且您已经登出,请再次登录。